Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1985 Oct;86(2):351–356. doi: 10.1111/j.1476-5381.1985.tb08903.x

The effects of chemical sympathectomy on dopamine, noradrenaline and adrenaline content in some peripheral tissues.

M M Caramona, P Soares-da-Silva
PMCID: PMC1916696  PMID: 3931730

Abstract

Dopamine, noradrenaline (NA) and adrenaline (Ad) depletion by 6-hydroxydopamine (6-OHDA) and pargyline plus 6-OHDA was investigated in the cat left ventricle, mesenteric and renal arteries, renal cortex, renal medulla and adrenal medulla. Catecholamine concentrations in plasma were also analyzed in these two experimental conditions. 6-OHDA alone or in combination with pargyline induced parallel decreases of NA and dopamine contents in the left ventricle. In the main trunk and proximal branches of the mesenteric artery and renal artery 6-OHDA selectively reduced NA without a parallel decrease in dopamine content. Previous treatment with pargyline abolished this selectivity. In the kidney of control animals, dopamine content was greater than could be attributed to its presence only in noradrenergic neurones. In the renal cortex 6-OHDA reduced significantly dopamine and NA contents, and in the renal medulla only NA levels were decreased by this drug. Pargyline plus 6-OHDA did not deplete the NA content either in the renal cortex or in the renal medulla, and only reduced significantly the dopamine content in the renal cortex. NA concentrations in plasma were increased by pargyline plus 6-OHDA whilst Ad remained unaffected. In the adrenal medulla only NA content was reduced either by 6-OHDA or pargyline plus 6-OHDA. The present findings suggest a NA-independent dopamine pool in both segments of the mesenteric artery and renal artery but not in the left ventricle.

Full text

PDF
351

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amenta F., Cavallotti C., De Rossi M., Sancesario G., Gerli R. 3H-spiroperidol binding sites in the rabbit superior mesenteric artery. A histoautoradiographic study. Pharmacology. 1984;28(2):104–111. doi: 10.1159/000137950. [DOI] [PubMed] [Google Scholar]
  2. Bell C., Gillespie J. S. Dopamine and noradrenaline levels in peripheral tissues of several mammalian species. J Neurochem. 1981 Feb;36(2):703–706. doi: 10.1111/j.1471-4159.1981.tb01645.x. [DOI] [PubMed] [Google Scholar]
  3. Bell C., Lang W. J., Laska F. Dopamine-containing axons supplying the arterio-venous anastomoses of the canine paw pad. J Neurochem. 1978 Nov;31(5):1329–1333. doi: 10.1111/j.1471-4159.1978.tb06259.x. [DOI] [PubMed] [Google Scholar]
  4. Bell C., Lang W. J., Laska F. Dopamine-containing vasomotor nerves in the dog kidney. J Neurochem. 1978 Jul;31(1):77–83. doi: 10.1111/j.1471-4159.1978.tb12435.x. [DOI] [PubMed] [Google Scholar]
  5. Bell C., Rome A. C. Pharmacological investigations of the vasodilator nerves supplying the duck's foot. Br J Pharmacol. 1984 Aug;82(4):801–808. doi: 10.1111/j.1476-5381.1984.tb16476.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bloom F. E., Algeri S., Groppetti A., Revuelta A., Costa E. Lesions of central norepinephrine terminals with 6-OH-dopamine: biochemistry and fine structure. Science. 1969 Dec 5;166(3910):1284–1286. doi: 10.1126/science.166.3910.1284. [DOI] [PubMed] [Google Scholar]
  7. Breese G. R., Traylor T. D. Effect of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective degeneration of catecholamine neurons. J Pharmacol Exp Ther. 1970 Sep;174(3):413–420. [PMC free article] [PubMed] [Google Scholar]
  8. Commissiong J. W., Galli C. L., Neff N. H. Differentiation of dopaminergic and noradrenergic neurons in rat spinal cord. J Neurochem. 1978 May;30(5):1095–1099. doi: 10.1111/j.1471-4159.1978.tb12403.x. [DOI] [PubMed] [Google Scholar]
  9. Costa E., Green A. R., Koslow S. H., LeFevre H. F., Revuelta A. V., Wang C. Dopamine and norepinephrine in noradrenergic axons: a study in vivo of their precursor product relationship by mass fragmentography and radiochemistry. Pharmacol Rev. 1972 Jun;24(2):167–190. [PubMed] [Google Scholar]
  10. Dinerstein R. J., Vannice J., Henderson R. C., Roth L. J., Goldberg L. I., Hoffmann P. C. Histofluorescence techniques provide evidence for dopamine-containing neuronal elements in canine kidney. Science. 1979 Aug 3;205(4405):497–499. doi: 10.1126/science.451614. [DOI] [PubMed] [Google Scholar]
  11. Goldberg L. I. Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacol Rev. 1972 Mar;24(1):1–29. [PubMed] [Google Scholar]
  12. Goldberg L. I., Volkman P. H., Kohli J. D. A comparison of the vascular dopamine receptor with other dopamine receptors. Annu Rev Pharmacol Toxicol. 1978;18:57–79. doi: 10.1146/annurev.pa.18.040178.000421. [DOI] [PubMed] [Google Scholar]
  13. Kirpekar S. M., Nobiletti J., Trifaró J. M. Effect of 6-hydroxydopamine on bovine adrenal chromaffin cells in culture. Br J Pharmacol. 1983 Aug;79(4):947–952. doi: 10.1111/j.1476-5381.1983.tb10540.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kostrzewa R. M., Jacobowitz D. M. Pharmacological actions of 6-hydroxydopamine. Pharmacol Rev. 1974 Sep;26(3):199–288. [PubMed] [Google Scholar]
  15. LEVITT M., SPECTOR S., SJOERDSMA A., UDENFRIEND S. ELUCIDATION OF THE RATE-LIMITING STEP IN NOREPINEPHRINE BIOSYNTHESIS IN THE PERFUSED GUINEA-PIG HEART. J Pharmacol Exp Ther. 1965 Apr;148:1–8. [PubMed] [Google Scholar]
  16. Lacković Z., Neff N. H. Evidence for the existence of peripheral dopaminergic neurons. Brain Res. 1980 Jul 7;193(1):289–292. doi: 10.1016/0006-8993(80)90969-5. [DOI] [PubMed] [Google Scholar]
  17. Lacković Z., Relja M. Evidence for a widely distributed peripheral dopaminergic system. Fed Proc. 1983 Oct;42(13):3000–3004. [PubMed] [Google Scholar]
  18. Lacković Z., Relja M., Neff N. H. Catabolism of endogenous dopamine in peripheral tissues: is there an independent role for dopamine in peripheral neurotransmission? J Neurochem. 1982 May;38(5):1453–1458. doi: 10.1111/j.1471-4159.1982.tb07925.x. [DOI] [PubMed] [Google Scholar]
  19. Lokhandwala M. F., Barrett R. J. Cardiovascular dopamine receptors: physiological, pharmacological and therapeutic implications. J Auton Pharmacol. 1982 Sep;2(3):189–215. doi: 10.1111/j.1474-8673.1982.tb00489.x. [DOI] [PubMed] [Google Scholar]
  20. Lokhandwala M. F., Buckley J. P. Presynaptic dopamine receptors as mediators of dopamine-induced inhibition of neurogenic vasoconstriction. Eur J Pharmacol. 1977 Oct 1;45(3):305–309. doi: 10.1016/0014-2999(77)90015-2. [DOI] [PubMed] [Google Scholar]
  21. STONE C. A., PORTER C. C., STAVORSKI J. M., LUDDEN C. T., TOTARO J. A. ANTAGONISM OF CERTAIN EFFECTS OF CATECHOLAMINE-DEPLETING AGENTS BY ANTIDEPRESSANT AND RELATED DRUGS. J Pharmacol Exp Ther. 1964 May;144:196–204. [PubMed] [Google Scholar]
  22. Snider S. R., Almgren O., Carlsson A. The occurrence and functional significance of dopamine in some peripheral adrenergic nerves of the rat. Naunyn Schmiedebergs Arch Pharmacol. 1973;278(1):1–12. doi: 10.1007/BF00501858. [DOI] [PubMed] [Google Scholar]
  23. Thoenen H., Tranzer J. P. Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-Hydroxydopamine. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1968;261(3):271–288. doi: 10.1007/BF00536990. [DOI] [PubMed] [Google Scholar]
  24. Udenfriend S. Tyrosine hydroxylase. Pharmacol Rev. 1966 Mar;18(1):43–51. [PubMed] [Google Scholar]
  25. Yeh B. K., McNay J. L., Goldberg L. I. Attenuation of dopamine renal and mesenteric vasodilation by haloperidol: evidence for a specific dopamine receptor. J Pharmacol Exp Ther. 1969 Aug;168(2):303–309. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES